1. Home
  2. CINGW vs AZO Comparison

CINGW vs AZO Comparison

Compare CINGW & AZO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CINGW
  • AZO
  • Stock Information
  • Founded
  • CINGW N/A
  • AZO 1979
  • Country
  • CINGW United States
  • AZO United States
  • Employees
  • CINGW 13
  • AZO N/A
  • Industry
  • CINGW Biotechnology: Pharmaceutical Preparations
  • AZO Auto & Home Supply Stores
  • Sector
  • CINGW Health Care
  • AZO Consumer Discretionary
  • Exchange
  • CINGW Nasdaq
  • AZO Nasdaq
  • Market Cap
  • CINGW N/A
  • AZO N/A
  • IPO Year
  • CINGW 2021
  • AZO 1991
  • Fundamental
  • Price
  • CINGW $0.04
  • AZO $3,652.11
  • Analyst Decision
  • CINGW
  • AZO Strong Buy
  • Analyst Count
  • CINGW 0
  • AZO 21
  • Target Price
  • CINGW N/A
  • AZO $3,722.14
  • AVG Volume (30 Days)
  • CINGW N/A
  • AZO 166.2K
  • Earning Date
  • CINGW N/A
  • AZO 05-20-2025
  • Dividend Yield
  • CINGW N/A
  • AZO N/A
  • EPS Growth
  • CINGW N/A
  • AZO 4.76
  • EPS
  • CINGW N/A
  • AZO 149.46
  • Revenue
  • CINGW N/A
  • AZO $18,672,517,000.00
  • Revenue This Year
  • CINGW N/A
  • AZO $2.56
  • Revenue Next Year
  • CINGW N/A
  • AZO $5.99
  • P/E Ratio
  • CINGW N/A
  • AZO $24.42
  • Revenue Growth
  • CINGW N/A
  • AZO 4.72
  • 52 Week Low
  • CINGW N/A
  • AZO $2,728.97
  • 52 Week High
  • CINGW N/A
  • AZO $3,916.81
  • Technical
  • Relative Strength Index (RSI)
  • CINGW N/A
  • AZO 52.13
  • Support Level
  • CINGW N/A
  • AZO $3,506.62
  • Resistance Level
  • CINGW N/A
  • AZO $3,700.35
  • Average True Range (ATR)
  • CINGW 0.00
  • AZO 117.33
  • MACD
  • CINGW 0.00
  • AZO -7.87
  • Stochastic Oscillator
  • CINGW 0.00
  • AZO 45.21

About CINGW Cingulate Inc.

Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic areas to use PTR technology to develop future product candidates.

Share on Social Networks: